Literature DB >> 19447427

A population based assessment of perioperative mortality after cystectomy for bladder cancer.

Hendrik Isbarn1, Claudio Jeldres, Laurent Zini, Paul Perrotte, Sara Baillargeon-Gagne, Umberto Capitanio, Shahrokh F Shariat, Phillipe Arjane, Fred Saad, Michael McCormack, Luc Valiquette, Francois Peloquin, Alain Duclos, Francesco Montorsi, Markus Graefen, Pierre I Karakiewicz.   

Abstract

PURPOSE: Large variability exists in the rates of perioperative mortality after cystectomy. Contemporary estimates range from 0.7% to 5.6%. We tested several predictors of perioperative mortality and devised a model for individual perioperative mortality prediction.
MATERIALS AND METHODS: We relied on life tables to quantify 30, 60 and 90-day mortality rates according to age, gender, stage (localized vs regional), grade, type of surgery (partial vs radical cystectomy), year of cystectomy and histological bladder cancer subtype. We fitted univariable and multivariable logistic regression models using 5,510 patients diagnosed with bladder cancer and treated with partial or radical cystectomy within 4 SEER (Surveillance, Epidemiology, and End Results) registries between 1984 and 2004. We then externally validated the model on 5,471 similar patients from 5 other SEER registries.
RESULTS: At 30, 60 and 90 days the perioperative mortality rates were 1.1%, 2.4% and 3.9%, respectively. Age, stage and histological subtype represented statistically significant and independent predictors of 90-day mortality. The combined use of these 3 variables and of tumor grade resulted in the most accurate model (70.1%) for prediction of individual probability of 90-day mortality after cystectomy.
CONCLUSIONS: The accuracy of our model could potentially be improved with the consideration of additional parameters such as surgical and hospital volume or comorbidity. While better models are being developed and tested we suggest the use of the current model in individual decision making and in informed consent considerations because it provides accurate predictions in 7 of 10 patients.

Entities:  

Mesh:

Year:  2009        PMID: 19447427     DOI: 10.1016/j.juro.2009.02.120

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  33 in total

Review 1.  [Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies].

Authors:  M Rink; F K Chun; T F Chromecki; H Fajkovic; R Dahlem; M Fisch; S F Shariat
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

2.  Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.

Authors:  Thomas F Chromecki; Julian Mauermann; Eugene K Cha; Robert S Svatek; Harun Fajkovic; Pierre I Karakiewicz; Yair Lotan; Derya Tilki; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Giacomo Novara; Hans-Martin Fritsche; Vincenzo Ficarra; Christian G Stief; Colin P Dinney; Eila Skinner; Karl Pummer; Yves Fradet; Shahrokh F Shariat
Journal:  World J Urol       Date:  2011-10-19       Impact factor: 4.226

3.  High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec.

Authors:  Fabiano Santos; Ahmed S Zakaria; Wassim Kassouf; Simon Tanguay; Armen Aprikian
Journal:  World J Urol       Date:  2014-12-04       Impact factor: 4.226

4.  Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.

Authors:  Atiqullah Aziz; Michael Gierth; Michael Rink; Marianne Schmid; Felix K Chun; Roland Dahlem; Florian Roghmann; Rein-Jüri Palisaar; Joachim Noldus; Jörg Ellinger; Stefan C Müller; Armin Pycha; Thomas Martini; Christian Bolenz; Rudolf Moritz; Edwin Herrmann; Bastian Keck; Bernd Wullich; Roman Mayr; Hans-Martin Fritsche; Maximilian Burger; Patrick J Bastian; Christian Seitz; Sabine Brookman-May; Evanguelos Xylinas; Shahrokh F Shariat; Margit Fisch; Matthias May
Journal:  World J Urol       Date:  2015-05-07       Impact factor: 4.226

5.  Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.

Authors:  Jennifer M Taylor; Andrew Feifer; Caroline J Savage; Alexandra C Maschino; Melanie Bernstein; Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2011-07-01       Impact factor: 5.588

6.  [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].

Authors:  M May; H-M Fritsche; C Gilfrich; S Brookman-May; M Burger; W Otto; C Bolenz; L Trojan; E Herrmann; M S Michel; C Wülfing; A Tiemann; S C Müller; J Ellinger; A Buchner; C G Stief; D Tilki; W F Wieland; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; O Müller; P Bretschneider-Ehrenberg; M Zacharias; S Gunia; P J Bastian
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

7.  Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.

Authors:  Meera R Chappidi; Max Kates; Hiten D Patel; Jeffrey J Tosoian; Deborah R Kaye; Nikolai A Sopko; Danny Lascano; Jen-Jane Liu; James McKiernan; Trinity J Bivalacqua
Journal:  Urol Oncol       Date:  2016-02-15       Impact factor: 3.498

8.  Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base.

Authors:  Matthew E Nielsen; Katherine Mallin; Mark A Weaver; Bryan Palis; Andrew Stewart; David P Winchester; Matthew I Milowsky
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

9.  Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009.

Authors:  Ahmed S Zakaria; Fabiano Santos; Alice Dragomir; Simon Tanguay; Wassim Kassouf; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

10.  Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians.

Authors:  Jerry J Trulson; Pranav Sharma; Tyler Haden; Emil Kheterpal; Naveen Pokala
Journal:  World J Urol       Date:  2013-07-02       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.